Summit Securities Group’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Summit Securities Group's PFE Position: Q2 2026 in Review
Summit Securities Group reduced its Pfizer (PFE) stake by 39% in Q2 2026, selling an estimated $425K and leaving 25,086 shares worth $604K. The position accounts for 0.06% of the portfolio, ranked #158.
Summit Securities Group first reported a position in PFE in Q2 2013 and has held it in 43 quarters since. The position peaked at $15.6M in Q4 2021. 2,827 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Summit Securities Group held 25,086 shares of Pfizer worth $604K as of Q2 2026.
- Summit Securities Group sold 16,248 Pfizer shares in Q2 2026, an estimated $425K.
- Pfizer made up 0.06% of Summit Securities Group's portfolio in Q2 2026, its #158 holding.
- Summit Securities Group first reported a position in Pfizer in Q2 2013 and has held it in 43 quarters since.
- Summit Securities Group's Pfizer position peaked at $15.6M in Q4 2021.
- 2,827 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Summit Securities Group's 13F filing for Q2 2026, filed 3 Aug 2026.